IFR US ECM Calendar
November 5: BWX Technologies (US, nuclear components) – $1bn 5y cvt marketed at 0%-0.5%, up 25%-30%. MS, JPM, WF, TD. Capped call.
November 5: Benitec Biopharma (US, biotech) ─ $100m ABB. Fixed size (Primary) marketed at $13.50 fixed price versus $15.78 last sale. LEER, TDC, EVER. Includes $25m via concurrent RDO with to 49.9% owner Survetta Capital. Wall cross.
November 5: BillionToOne (US, diagnostics) ─ $211.5m IPO. 3.8m shares (Primary) at $49-$55. JPM, PS, JEFF, WBLR. Nasdaq “BLLN”. 5% DSP.
November 5: CCC Intelligent Solutions (US, software) ─ $292.8m Block. 37.3m shares (Secondary) at $7.79-$7.84 versus $7.84 last sale. GS. Advent International is the selling shareholder.
November 5: Evommune (US, biotech) ─ $159.4m IPO. 9.4m shares (Primary) at $15-$17. MS, LEER, EVER, CANT. NYSE "EVMN".
November 5: First Watch Restaurant (US, restaurants) ─ $95.1m Block. 5.3m shares (secondary) versus $17.94 last sale. CITI. Advent International is the selling shareholder.
November 5: Grupo Aeromexico (Mexico, airline) ─ $234.5m IPO. 11.7m ADSs (Primary, Secondary) at $18-$20. BARC, MS, JPM, EVER. NYSE “AERO”. PAR Investment Partners investing $25m in a concurrent private placement. Apollo Global and Strategic Value Partners are among the selling shareholders. Emerged from bankruptcy in March 2022.
November 6: Halozyme Therapeutics (US, healthcare) ─ $650m 5.5y cvt marketed at fixed zero-percent coupon, up 25%-30%. BOFA, MS. Capped call. Repurchase 0.25% CB due 2027, 1% CB due 2028 for cash.
November 6: Halozyme Therapeutics (US, healthcare) ─ $650m 7y cvt marketed at 0.875% fixed coupon, up 25%-30%. BOFA, MS. Capped call. Repurchase 0.25% CB due 2027, 1% CB due 2028 for cash.
November 6: Novanta (US, laser equipment) ─ $550 3y cvt marketed at 6.25%-6.75%, up 20%-25%. JPM, BOFA. Offering consists of 11m tangible equity units at a $50.00 fixed price.
November 6: Voyager Technologies (US, aerospace & defense) ─ $300m 5y cvt marketed at 0.5%-1%, up 27.5%-32.5%. JPM, MS, BOFA. Capped call. Prepaid forward and concurrent $175m stock buyback to facilitate delta hedging.
November 10: Public Policy (US, public affairs) ─ $60m Nasdaq IPO. 4.1m shares (Primary, Secondary) versus $14.64 reference price at launch. OPCO, CGEN. Nasdaq “PPHC”. Cross-listing of common shares trading on LSE AIM market under the symbol “PPHC” at £10.90 ($14.64) at launch. Pricing date based on automatic effectiveness 20 days from 10/21 S-1/A filing.
November 20: Central Bancompany (US, banking) ─ $426.7m IPO. 17.8m shares (Primary) at $21-$24. MS, KBW. Nasdaq "CBC". Uplisting from OTC trading venue under symbol "CBCY". Pricing date based on automatic effectiveness 20 days from 10/31 S-1/A filing.